NovaVive Inc. Hires a Senior Vice-President, U.S. Sales & Marketing
NovaVive is pleased to welcome Robert (Bob) Barclay as Senior Vice-President, U.S. Sales & Marketing effective January 1, 2018. Bob has several years of experience in animal health, including 11 years with Zoetis Inc.
Iowa State University College of Veterinary Medicine to Conduct a Study with Immunocidin® Equine in Two Types of Cancer
NovaVive's Immunocidin® Equine anticancer immunotherapeutic for horses will be evaluated in a clinical study at Iowa State University (ISU) College of Veterinary Medicine in sarcoids and squamous cell carcinoma.
Settle®, an Antibiotic Alternative for Treating Equine Endometritis, is Now Approved for Sale in New Zealand
NovaVive's immunotherapeutic for the treatment of equine endometritis, Settle®, has been approved for sale to New Zealand veterinarians by the NZ regulator. It was previously approved for sale in the U.S. and Australia.